Haemonetics (HAE) Tops Q1 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $120.14 +0.41%
Revenue Growth %: +5.6%
Financial Fact:
Net income: 19.83M
Today's EPS Names:
IEP, XPRO, GEF, More
Revenue Growth %: +5.6%
Financial Fact:
Net income: 19.83M
Today's EPS Names:
IEP, XPRO, GEF, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $1.10, $0.09 better than the analyst estimate of $1.01. Revenue for the quarter came in at $321.39 million versus the consensus estimate of $302.62 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Reiterated at Market Outperform by Citizens - 'One of the Best Deep-Value Stories'
- ADTRAN, Inc. (ADTN) Tops Q3 EPS by 5c; offers guidance
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
